| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/12/2002 | EP1023287B1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0885221B1 Azabicyclic esters of carbamic acids useful in therapy |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0876158B1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
| 06/12/2002 | EP0873320B1 Piperazine derivatives as tachykinin antagonists |
| 06/12/2002 | EP0841933B1 Bowman-Birk inhibitor compositions for treatment of inflammatory disease |
| 06/12/2002 | EP0817864B1 Method for the diagnosis of crohn's disease and ulcerative colitis |
| 06/12/2002 | EP0813407B1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 06/12/2002 | EP0717625B1 A method of treating liver disease and like indications with vasodilating agents |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353712A Polymorphs of crystalline (2-benzhydryl-2-azabicyclo [2.2.2] OCT-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists |
| 06/12/2002 | CN1353711A Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 06/12/2002 | CN1353710A 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 06/12/2002 | CN1353708A Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 06/12/2002 | CN1353707A aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353574A Disinfecting composition based on H2O2 acids and metal ions |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1353181A Process for preparing healht-care wine |
| 06/12/2002 | CN1352988A Exterior-applied Chinese medicine for treating cold in stomach |
| 06/12/2002 | CN1352981A Medicine for treating toothache |
| 06/12/2002 | CN1352978A Medicine 'Shenfeishu' for treating nephrosis and lung disease and its preparing process |
| 06/12/2002 | CN1352970A Chinese patent medicine for treating colitis |
| 06/12/2002 | CN1352967A Medicine for treating chronic gastritis and gastric ulcer |
| 06/12/2002 | CN1352962A Mongolian medicine prepared by enzyme engineering for treating gastrosis and its preparing process |
| 06/12/2002 | CN1352960A Compound Qiling capsule for beautifying face and its preparing process |
| 06/12/2002 | CN1352955A Throat-protecting medicine |
| 06/12/2002 | CN1352952A Prescription of Pugonglian Herbal medicine |
| 06/12/2002 | CN1352951A Prescription of Daolu powder |
| 06/12/2002 | CN1352946A Nutrient 'Lingguyiyuan' and its preparing process |
| 06/12/2002 | CN1086144C Capsule for tonifying kidney |
| 06/12/2002 | CN1086143C Medicine for treating active-stage hepatitis B and its preparing process |
| 06/12/2002 | CN1086142C Medicine for treating resting-stage hepatitis B and its preparing process |
| 06/12/2002 | CN1086141C Medicine for treating early-stage hepatocirrhosis and its preparing process |
| 06/12/2002 | CN1086139C Chinese patent medicine for curing hepatitis B |
| 06/12/2002 | CN1086134C Gastrosis treating medicine and its preparing process |
| 06/12/2002 | CN1086129C Medicine for treating hepatitis |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403775 Erythronolide compounds |
| 06/11/2002 | US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine |
| 06/11/2002 | US6403638 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors |
| 06/11/2002 | US6403618 Administering picolinic acid derivatives to chelate with zinc and iron in proteins; antiangiogenic and antineoplastic agent |
| 06/11/2002 | US6403616 Chemical process and pharmaceutical formulation |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403607 Sulfonamide derivatives and drugs containing the same as the active ingredient |
| 06/11/2002 | US6403604 Nitrogen-based camptothecin derivatives |
| 06/11/2002 | US6403601 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
| 06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403565 Enhances dna repair and prevents consequences of mutagenic radiation even when administered after damage or exposure to radiation has already occurred; deoxyribonucleosides: deoxycytidine, deoxyadenosine, deoxyguanosine, and thymidine. |
| 06/11/2002 | US6403561 Disorders associated with the inactivation or excessive degradation of cholecystokinin; inhibiting the enzymatic hydrolysis of cholecystokinin 1-(2(s)-aminobutyryl)-2(s)-indolinecarboxylic acid |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/11/2002 | US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease |
| 06/11/2002 | US6403060 Anticaries agent; dissolving liquid |
| 06/11/2002 | CA2239705C Quinazoline-4-one ampa antagonists |
| 06/06/2002 | WO2002044393A1 Recombinant viral and non-viral vectors containing the human urokinase plasminogen activator gene and its utilization in the treatment of various types of hepatic, renal, pulmonary, pancreatic and cardiac fibrosis and hypertrophic scars |
| 06/06/2002 | WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | WO2002044368A1 Novel g protein-coupled receptor proteins and dnas thereof |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044179A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2002 | WO2002044176A1 3-substituted quinuclidines and their use as nicotinic agonists |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044167A1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044160A1 Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044152A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 06/06/2002 | WO2002044149A1 Indole and dihydroindole derivatives |
| 06/06/2002 | WO2002044142A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 06/06/2002 | WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 06/06/2002 | WO2002044139A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/06/2002 | WO2002043771A2 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | WO2002043753A1 Remedies for chronic hepatitis b |
| 06/06/2002 | WO2002043752A1 Interferon therapeutic effect-potentiating agents |
| 06/06/2002 | WO2002043741A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043733A1 Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043649A2 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |